Clinical Trial Supply and Logistics Market: Adapting to Changes in Clinical Protocols

The global clinical trial supply and logistics market was estimated at USD 4,287.8 million in 2024 and is projected to reach USD 6,722.9 million by 2030, growing at a compound annual growth rate (CAGR) of 7.97% from 2025 to 2030. Key factors driving the growth of the clinical trial supply and logistics market include globalization, an increasing number of clinical trials, and rising R&D expenditures by pharmaceutical and biopharmaceutical companies.

Rapid technological advancements in supply chain management are significantly contributing to market growth. The increasing complexity of clinical studies is leading to the adoption of new technologies for efficient and rapid supply chain operations. The rising implementation of precision medicine, biologics, and decentralized trials has further complicated supply chains. Advanced therapies necessitate stringent temperature controls, customized packaging, and real-time tracking to maintain product integrity. This has created a demand for specialized logistics providers capable of managing these intricate supply chains, thereby promoting market expansion.

Additionally, pharmaceutical and biotech companies are increasingly outsourcing supply chain operations to third-party logistics (3PL) providers to streamline processes and reduce costs. This shift allows sponsors to focus on their core research while leveraging logistics firms' expertise in risk management and inventory optimization. Consequently, strategic partnerships and mergers within the logistics sector are expanding service offerings, enhancing efficiency, and driving overall market growth. For example, in September 2024, Tower Cold Chain partnered with CRYOPDP to enhance their offerings within the pharmaceutical supply chain, particularly for clinical research. This partnership aims to provide a wider range of advanced temperature-controlled solutions to meet the evolving needs of patients.

**** 

Key Market Trends & Insights

• North America led the market with a revenue share of 38.33% in 2024, primarily due to the high number of clinical trials conducted in the region. A significant increase in investments in clinical trials, along with a rise in participants in the clinical trial supply and logistics market, is expected to drive growth.
• Within North America, the U.S. clinical trial supply and logistics market holds a dominant position.
• By service type, the logistics and distribution segment accounted for the largest share at 25.3% in 2024, driven by increasing trial complexity, globalization, and stringent regulatory requirements. The demand for temperature-controlled transportation, just-in-time deliveries, and real-time shipment tracking is fueling investments in advanced cold chain logistics.
• By phase, the phase II segment is projected to experience substantial growth during the forecast period. This growth is attributed to an increase in clinical trial activities, extensive patient enrollment, complex trial protocols, stringent regulatory requirements, and a high failure rate in this phase, resulting in significant financial and human costs.
• By therapeutic area, the cardiovascular diseases segment captured the largest market share in 2024. This is driven by a rising disease burden, numerous companies focusing on developing innovative treatments for heart diseases, and strategies aimed at reducing the prevalence of heart attacks and strokes.

**** 

Order a free sample PDF of the Clinical Trial Supply And Logistics Market Intelligence Study, published by Grand View Research.

**** 

Market Size & Forecast

• 2024 Market Size: USD 4,287.8 Million
• 2030 Projected Market Size: USD 6,722.9 Million
• CAGR (2025-2030): 7.97%
• North America: Largest market in 2024

**** 

Key Companies & Market Share Insights

Prominent players in the clinical trial supply and logistics market include Thermo Fisher Scientific (Patheon), Catalent, Inc., Parexel, UPS Healthcare, Piramal Pharma Solutions, Almac Group, UDG Healthcare, FedEx, Movianto, DHL, and Packaging Coordinators Inc. These companies are actively expanding their facilities and engaging in collaborations, partnerships, mergers, and acquisitions to influence industry dynamics. For instance, in July 2024, Catalent, Inc. completed the expansion of its clinical supply facility in Schorndorf, Germany, enhancing its packaging, storage, and distribution capabilities. This facility aims to bolster clinical supply services to support global drug development and improve patient access to innovative treatments.

**** 

Key Players

• Thermo Fisher Scientific Inc.
• UPS Healthcare
• Piramal Pharma Solutions
• DHL
• Parexel International
• Almac Group
• Movianto
• UDG Healthcare
• FedEx
• Catalent, Inc.

**** 

Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.

**** 

Conclusion

The clinical trial supply and logistics market is poised for significant growth due to globalization, technological advancements, and increasing complexities in clinical trials. The trend towards outsourcing supply chain operations and the rising need for specialized logistics services further enhances the market's potential. As the industry evolves, partnerships and strategic initiatives among key players will play a critical role in driving innovation and efficiency, ensuring better outcomes for clinical trials and patient care.